| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 4, Issue 5 385-388, Copyright © 1997 by Society of Surgical Oncology
ARTICLES |
P. I. Borgen, R. T. Senie, W. M. McKinnon and P. P. Rosen
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.
BACKGROUND: Considerable debate exists concerning the prognosis of breast cancer in male patients compared with that in female patients. Some studies have observed worse prognosis for men; others suggested the higher mortality rates were primarily due to delayed diagnosis. METHODS: Survival time from diagnosis with invasive disease to death resulting from breast cancer of 58 men treated between 1973 and 1989 was compared with survival of 174 women treated between 1976 and 1978 who were matched by stage of disease and age at diagnosis. All patients were treated by mastectomy and axillary dissection. RESULTS: Tumors were < or = 2 cm in 70% of cases and 55% were free of axillary metastases. The histology of the tumors differed significantly by gender (p < 0.05). Significantly more men had estrogen receptor-positive tumors (87%) than did women (55%, p < 0.001). Survival at 10 years was similar for male and female patients. Multivariate analysis controlling for tumor size, number of positive axillary lymph nodes, age at diagnosis, histology, and receptor status indicated no significant difference in survival of male compared with female patients. CONCLUSIONS: These data conflict with the conventional wisdom that breast cancer in men carries a worse prognosis than the disease in women. Although histology of the tumor and receptor status differed by gender, these factors did not have an impact on survival in these paired patients. Our data indicate that breast carcinoma in males is not biologically more aggressive than in females.
This article has been cited by other articles:
![]() |
O. Gentilini, E. Chagas, S. Zurrida, M. Intra, C. De Cicco, G. Gatti, L. Silva, G. Renne, E. Cassano, and U. Veronesi Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer Oncologist, May 1, 2007; 12(5): 512 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Macdonald, C. Paltiel, I. A. Olivotto, and S. Tyldesley A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer Ann. Onc., September 1, 2005; 16(9): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. El-Tamer, I. K. Komenaka, A. Troxel, H. Li, K.-A. Joseph, B.-A. Ditkoff, F. R. Schnabel, and D. W. Kinne Men With Breast Cancer Have Better Disease-Specific Survival Than Women Arch Surg, October 1, 2004; 139(10): 1079 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Giordano, A. U. Buzdar, and G. N. Hortobagyi Breast Cancer in Men Ann Intern Med, October 15, 2002; 137(8): 678 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Smolin and M. J. Massie Male Breast Cancer: A Review of the Literature and a Case Report Psychosomatics, August 1, 2002; 43(4): 326 - 330. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |